Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 230

1.

"Not for human consumption": a review of emerging designer drugs.

Musselman ME, Hampton JP.

Pharmacotherapy. 2014 Jul;34(7):745-57. doi: 10.1002/phar.1424. Review.

PMID:
24710806
2.

Bath salts and synthetic cathinones: an emerging designer drug phenomenon.

German CL, Fleckenstein AE, Hanson GR.

Life Sci. 2014 Feb 27;97(1):2-8. doi: 10.1016/j.lfs.2013.07.023. Review.

3.

Designer drugs in psychiatric practice - a review of the literature and the recent situation in Hungary.

Szily E, Bitter I.

Neuropsychopharmacol Hung. 2013 Dec;15(4):223-31. Review.

5.

New synthetic drugs in addictovigilance.

Chavant F, Boucher A, Le Boisselier R, Deheul S, Debruyne D.

Therapie. 2015 Mar-Apr;70(2):167-89. doi: 10.2515/therapie/2015001. English, French.

PMID:
25858573
6.

Nephrotoxic effects of designer drugs: synthetic is not better!

Luciano RL, Perazella MA.

Nat Rev Nephrol. 2014 Jun;10(6):314-24. doi: 10.1038/nrneph.2014.44. Review.

PMID:
24662435
7.

Baths salts, spice, and related designer drugs: the science behind the headlines.

Baumann MH, Solis E Jr, Watterson LR, Marusich JA, Fantegrossi WE, Wiley JL.

J Neurosci. 2014 Nov 12;34(46):15150-8. doi: 10.1523/JNEUROSCI.3223-14.2014. Review.

8.

Synthetic cathinones ("bath salts").

Banks ML, Worst TJ, Rusyniak DE, Sprague JE.

J Emerg Med. 2014 May;46(5):632-42. doi: 10.1016/j.jemermed.2013.11.104. Review.

PMID:
24565885
9.

Synthetic legal intoxicating drugs: the emerging 'incense' and 'bath salt' phenomenon.

Jerry J, Collins G, Streem D.

Cleve Clin J Med. 2012 Apr;79(4):258-64. doi: 10.3949/ccjm.79a.11147. Review.

10.

[New psychoactive substances and their prevalence in the Czech Republic].

Mravčík V, Běláčková V, Grohmannová K, Zábranský T.

Cas Lek Cesk. 2015;154(5):216-21. Czech.

PMID:
26612328
11.

Crystallographic investigations of select cathinones: emerging illicit street drugs known as `bath salts'.

Wood MR, Lalancette RA, Bernal I.

Acta Crystallogr C Struct Chem. 2015 Jan;71(Pt 1):32-8. doi: 10.1107/S2053229614025637.

PMID:
25567572
12.

Designer drugs 2015: assessment and management.

Weaver MF, Hopper JA, Gunderson EW.

Addict Sci Clin Pract. 2015 Mar 25;10:8. doi: 10.1186/s13722-015-0024-7.

13.

Forensic investigation of K2, Spice, and "bath salt" commercial preparations: a three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds.

Seely KA, Patton AL, Moran CL, Womack ML, Prather PL, Fantegrossi WE, Radominska-Pandya A, Endres GW, Channell KB, Smith NH, McCain KR, James LP, Moran JH.

Forensic Sci Int. 2013 Dec 10;233(1-3):416-22. doi: 10.1016/j.forsciint.2013.10.002.

PMID:
24314548
14.

[Recreational drugs: the complication's pleasure?].

Joye F, Donzé N, Frochaux V, Niquille M, Selz Amaudruz F.

Rev Med Suisse. 2013 Aug 14;9(394):1454-60. French.

PMID:
24024389
15.

The New Designer Drug Wave: A Clinical, Toxicological, and Legal Analysis.

Abbott R, Smith DE.

J Psychoactive Drugs. 2015 Nov-Dec;47(5):368-71. doi: 10.1080/02791072.2015.1094591. Review.

PMID:
26579784
16.
17.

Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.

Liechti M.

Swiss Med Wkly. 2015 Jan 14;145:w14043. doi: 10.4414/smw.2015.14043. Review.

18.

Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food".

Coppola M, Mondola R.

Toxicol Lett. 2012 Jun 1;211(2):144-9. doi: 10.1016/j.toxlet.2012.03.009. Review.

PMID:
22459606
19.

"Legal highs" - new players in the old drama.

Zawilska JB.

Curr Drug Abuse Rev. 2011 Jun;4(2):122-30. Review.

PMID:
21711229
20.

The Toxicology of New Psychoactive Substances: Synthetic Cathinones and Phenylethylamines.

Tyrkkö E, Andersson M, Kronstrand R.

Ther Drug Monit. 2016 Apr;38(2):190-216. doi: 10.1097/FTD.0000000000000263. Review.

PMID:
26587869
Items per page

Supplemental Content

Support Center